Related Experiment Video
Updated: Aug 10, 2026
05:09
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
Published on: November 25, 2012
Ribozyme gene therapy for autosomal dominant retinal disease
W W Hauswirth1, M M LaVail, J G Flannery
1Department of Molecular Genetics and Microbiology, University of Florida College of Medicine, Gainesville 32610-0266, USA. hauswrth@eye1.eye.ufl.edu
Clinical Chemistry and Laboratory Medicine
|June 2, 2000
Summary
Ribozyme gene therapy shows promise for autosomal dominant retinal diseases. Adeno-associated virus vectors efficiently deliver ribozymes to photoreceptor cells, with successful testing in a retinitis pigmentosa rat model.
Area of Science:
- Ophthalmology
- Molecular Biology
- Gene Therapy
Background:
- Gene delivery to retinal photoreceptor cells offers potential for basic research and therapeutic applications.
- Autosomal dominant retinal diseases are a target for ribozyme-based therapies.
- Developing effective gene delivery methods is crucial for retinal treatments.
Purpose of the Study:
- To discuss the theoretical and practical basis for using ribozymes in treating autosomal dominant retinal diseases.
- To explore the use of adeno-associated virus (AAV) vectors for efficient and long-term gene expression in photoreceptor cells.
- To detail the evaluation of ribozyme efficacy and therapeutic outcomes in an animal model.
Main Methods:
- Designing and testing ribozymes in vitro for specific mutant versus wild-type RNA targeting.
- Utilizing adeno-associated virus vectors with a rod photoreceptor-specific opsin promoter for gene delivery.
- Evaluating therapeutic effects in a transgenic rat model of retinitis pigmentosa using biochemical, structural, and physiological assays.
Main Results:
- Adeno-associated virus vectors coupled with the opsin promoter enable efficient, long-term ribozyme expression in photoreceptor cells.
- In vitro analysis demonstrated ribozymes' ability to specifically distinguish between mutant and wild-type RNAs.
- Ribozyme therapy in a retinitis pigmentosa rat model showed potential rescue effects.
Conclusions:
- Ribozyme therapy, delivered via AAV vectors, is a viable strategy for autosomal dominant retinal diseases.
- Efficient and specific ribozyme design is critical for therapeutic success.
- Comprehensive analysis in animal models is essential to validate therapeutic efficacy in retinal gene therapy.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:47Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:47Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...